{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:11:28Z","timestamp":1793841088166,"version":"4.6.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Contracept Reprod Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hormonal pretreatment prior to controlled ovarian stimulation (COS) in assisted reproductive technology (ART) is widely used to improve follicular synchronization and schedule flexibility. However, the comparative impact of different pretreatment strategies\u2014progestin-only, combined oral contraceptive pills (COCP), and no pretreatment\u2014on follicular dynamics and clinical outcomes remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective cohort study, 240 patients undergoing their first IVF\/ICSI cycle with a GnRH antagonist protocol and recombinant FSH monotherapy were analyzed. Participants were divided into three groups: progestin-only pretreatment (P group), COCP pretreatment (COCP group), and no pretreatment (control group). Baseline characteristics, follicular development, embryo quality, and cumulative reproductive outcomes were compared. Levene\u2019s test was used to assess follicular size variability, and multivariable regression analyses were performed to adjust for confounding variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The P group demonstrated significantly improved follicular synchronization, as evidenced by the lowest variability in the ratio of follicles\u2009\u2265\u200918\u00a0mm to \u2265\u200914\u00a0mm. Embryological outcomes were superior in the P group, with higher oocyte maturation rate (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.040), fertilization rate (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.038), and number of good-quality blastocysts (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.015) compared to the other groups. The blastocyst development rate was also significantly greater (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.029). Although cumulative live birth rate (CLBR) did not reach statistical significance, a trend toward higher CLBR was observed in the P group (87.0%) compared to COCP (72.0%) and control (75.2%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Progestin-only pretreatment leads to superior follicular synchronization and improved embryo developmental potential in GnRH antagonist IVF\/ICSI cycles. These benefits may enhance ART efficiency and contribute to improved cumulative outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40834-025-00396-x","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:24:52Z","timestamp":1758705892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Progestin-only pretreatment enhances follicular synchronization and embryo development: a three-arm retrospective cohort study in GnRH antagonist cycles"],"prefix":"10.1186","volume":"10","author":[{"given":"Masato","family":"Kobanawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"396_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/AOG.0b013e3181cb50b5","volume":"115","author":"ACOG Practice Bulletin No","year":"2010","unstructured":"ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives. Obstet Gynecol. 2010;115:206\u201318.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"396_CR2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.rbmo.2016.07.010","volume":"33","author":"S D\u2019Arpe","year":"2016","unstructured":"D\u2019Arpe S, Di Feliciantonio M, Candelieri M, Franceschetti S, Piccioni MG, Bastianelli C. Ovarian function during hormonal contraception assessed by endocrine and sonographic markers: a systematic review. Reprod Biomed Online. 2016;33(4):436\u201348.","journal-title":"Reprod Biomed Online"},{"key":"396_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/humrep\/del340","volume":"22","author":"I C\u00e9drin-Durnerin","year":"2007","unstructured":"C\u00e9drin-Durnerin I, Bst\u00e4ndig B, Parneix I, Bied-Damon V, Avril C, Decanter C, et al. Effects of oral contraceptive, synthetic progestogen or natural Estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum Reprod. 2007;22:109\u201316.","journal-title":"Hum Reprod"},{"key":"396_CR4","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.fertnstert.2007.07.1354","volume":"90","author":"G Griesinger","year":"2008","unstructured":"Griesinger G, Venetis CA, Marx T, Diedrich K, Tarlatzis BC, Kolibianakis EM. Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis. Fertil Steril. 2008;90:1055\u201363.","journal-title":"Fertil Steril"},{"issue":"12","key":"396_CR5","first-page":"e76371","volume":"16","author":"M Kobanawa","year":"2024","unstructured":"Kobanawa M, Iwami N, Hanaoka M, Enatsu K, Ichiyama T. Cost-Effectiveness and clinical outcomes of controlled ovarian stimulation with follitropin delta and follitropin alfa: A retrospective study. Cureus. 2024;16(12):e76371.","journal-title":"Cureus"},{"key":"396_CR6","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.","edition":"2"},{"key":"396_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","volume":"18","author":"H Kang","year":"2021","unstructured":"Kang H. Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof. 2021;18:17.","journal-title":"J Educ Eval Health Prof"},{"issue":"1","key":"396_CR8","doi-asserted-by":"publisher","first-page":"e12499","DOI":"10.1002\/rmb2.12499","volume":"22","author":"M Kobanawa","year":"2023","unstructured":"Kobanawa M. The gonadotropins starting dose calculator, which can be adjusted the target number of oocytes and stimulation duration days to achieve individualized controlled ovarian stimulation in Japanese patients. Reprod Med Biol. 2023;22(1):e12499.","journal-title":"Reprod Med Biol"},{"key":"396_CR9","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/humrep\/dex219","volume":"32","author":"S Iliodromiti","year":"2017","unstructured":"Iliodromiti S, Salje B, Dewailly D, et al. Non-equivalence of anti-M\u00fcllerian hormone automated assays-clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing. Hum Reprod. 2017;32:1710\u20135.","journal-title":"Hum Reprod"},{"key":"396_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00001703-199906000-00013","volume":"11","author":"DK Gardner","year":"1999","unstructured":"Gardner DK, Schoolcraft WB. Culture and transfer of human blastocysts. Curr Opin Obstet Gynecol. 1999;11:307\u201311.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"396_CR11","first-page":"2703","volume":"30","author":"A Maheshwari","year":"2015","unstructured":"Maheshwari A, McLernon D, Bhattacharya S. Cumulative live birth rate: time for a consensus? Hum Reprod. 2015;30:2703\u20137.","journal-title":"Hum Reprod"},{"issue":"3","key":"396_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48(3):452\u20138.","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"396_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/0960-0760(92)90260-P","volume":"42","author":"LA Lesoon","year":"1992","unstructured":"Lesoon LA, Mahesh VB. Stimulatory and inhibitory effects of progesterone on FSH secretion by the anterior pituitary. J Steroid Biochem Mol Biol. 1992;42(5):479\u201391.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"396_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1095\/biolreprod67.1.119","volume":"67","author":"TA Richter","year":"2002","unstructured":"Richter TA, Robinson JE, Evans NP. Progesterone blocks the estradiol-stimulated luteinizing hormone surge by disrupting activation in response to a stimulatory estradiol signal in the Ewe. Biol Reprod. 2002;67(1):119\u201325.","journal-title":"Biol Reprod"},{"issue":"18","key":"396_CR15","doi-asserted-by":"publisher","first-page":"10978","DOI":"10.1073\/pnas.95.18.10978","volume":"95","author":"DC Skinner","year":"1998","unstructured":"Skinner DC, Evans NP, Delaleu B, Goodman RL, Bouchard P, Caraty A. The negative feedback actions of progesterone on gonadotropin-releasing hormone secretion are transduced by the classical progesterone receptor. Proc Natl Acad Sci U S A. 1998;95(18):10978\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"396_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0015-0282(01)01824-6","volume":"76","author":"A Obruca","year":"2001","unstructured":"Obruca A, Korver T, Huber J, Killick SR, Landgren B, Struijs MJ. Ovarian function during and after treatment with the new progestagen org 30659. Fertil Steril. 2001;76(1):108\u201315.","journal-title":"Fertil Steril"},{"key":"396_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0010-7824(95)00255-3","volume":"53","author":"O Heikinheimo","year":"1995","unstructured":"Heikinheimo O, Gordon K, Williams RF, Hodgen GD. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions. Contraception. 1995;53:55\u201364.","journal-title":"Contraception"},{"issue":"3","key":"396_CR18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1152\/physrev.00037.2010","volume":"92","author":"L Pinilla","year":"2012","unstructured":"Pinilla L, Aguilar E, Dieguez C, Millar RP, Tena-Sempere M. Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol Rev. 2012;92(3):1235\u2013316.","journal-title":"Physiol Rev"},{"issue":"5","key":"396_CR19","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1073\/pnas.0409330102","volume":"102","author":"S Messager","year":"2005","unstructured":"Messager S, Chatzidaki EE, Ma D, Hendrick AG, Zahn D, Dixon J, et al. Kisspeptin directly stimulates Gonadotropin-Releasing hormone release via G Protein-Coupled receptor 54. Proc Natl Acad Sci USA. 2005;102(5):1761\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"396_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000356903","volume":"99","author":"E Hrabovszky","year":"2014","unstructured":"Hrabovszky E. Neuroanatomy of the human hypothalamic Kisspeptin system. Neuroendocrinology. 2014;99(1):33\u201348.","journal-title":"Neuroendocrinology"},{"issue":"1","key":"396_CR21","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1038\/s41598-017-08805-1","volume":"7","author":"W He","year":"2017","unstructured":"He W, Li X, Adekunbi D, Liu Y, Long H, Wang L, et al. Hypothalamic effects of progesterone on regulation of the pulsatile and surge release of luteinising hormone in female rats. Sci Rep. 2017;7(1):8096.","journal-title":"Sci Rep"},{"issue":"35","key":"396_CR22","doi-asserted-by":"publisher","first-page":"8691","DOI":"10.1523\/JNEUROSCI.1775-08.2008","volume":"28","author":"J Clarkson","year":"2008","unstructured":"Clarkson J, d\u2019Anglemont de Tassigny X, Moreno AS, Colledge WH, Herbison AE. Kisspeptin-GPR54 signaling is essential for preovulatory Gonadotropin-Releasing hormone neuron activation and the luteinizing hormone surge. J Neurosci Off J Soc Neurosci. 2008;28(35):8691\u20137.","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"3","key":"396_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1530\/JOE-15-0429","volume":"228","author":"D Fernandois","year":"2016","unstructured":"Fernandois D, Na E, Cuevas F, Cruz G, Lara HE, Paredes AH. Kisspeptin is involved in ovarian follicular development during aging in rats. J Endocrinol. 2016;228(3):161\u201370.","journal-title":"J Endocrinol"},{"issue":"1","key":"396_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.contraception.2008.02.020","volume":"78","author":"JW Goldzieher","year":"2008","unstructured":"Goldzieher JW, Stanczyk FZ. Oral contraceptives and individual variability of Circulating levels of Ethinyl estradiol and progestins. Contraception. 2008;78(1):4\u20139.","journal-title":"Contraception"},{"issue":"3","key":"396_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/humrep\/13.3.561","volume":"13","author":"D Ziegler","year":"1998","unstructured":"Ziegler D, Jaaskelainen AS, Brioschi PA, Fanchin R, Bulletti C. Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH). Hum Reprod. 1998;13(3):561\u20134.","journal-title":"Hum Reprod"},{"issue":"2","key":"396_CR26","first-page":"439","volume":"77","author":"E Nestour","year":"1993","unstructured":"Nestour E, Marraoui J, Lahlou N, Roger M, Ziegler D, Bouchard P. Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal\u2010follicular transition. J Clin Endocrinol Metab. 1993;77(2):439\u201342.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"396_CR27","doi-asserted-by":"publisher","first-page":"e1007848","DOI":"10.1371\/journal.pcbi.1007848","volume":"16","author":"AA Wright","year":"2020","unstructured":"Wright AA, Fayad GN, Selgrade JF, Olufsen MS. Mechanistic model of hormonal contraception. PLoS Comput Biol. 2020;16(6):e1007848.","journal-title":"PLoS Comput Biol"},{"key":"396_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/09513599509160463","volume":"9","author":"AT Teichmann","year":"1995","unstructured":"Teichmann AT, Brill K, Albring M, Schnitker J, Wojtynek P, Kustra E. The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth. Gynecol Endocrinol. 1995;9:299\u2013305.","journal-title":"Gynecol Endocrinol"},{"key":"396_CR29","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S0015-0282(16)61036-1","volume":"52","author":"SS Thatcher","year":"1989","unstructured":"Thatcher SS, Jones E, DeCherney AH. Ovarian cysts decrease the success of controlled ovarian stimulation and in vitro fertilization. Fertil Steril. 1989;52:812\u20136.","journal-title":"Fertil Steril"},{"key":"396_CR30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S0015-0282(16)57794-2","volume":"64","author":"MD Keltz","year":"1995","unstructured":"Keltz MD, Jones EE, Duleba AJ, Polcz T, Kennedy K, Olive DL. Baseline cyst formation after luteal phase gonadotropin-releasing hormone agonist administration is linked to poor in vitro fertilization outcome. Fertil Steril. 1995;64:568\u201372.","journal-title":"Fertil Steril"},{"key":"396_CR31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0015-0282(98)00449-X","volume":"71","author":"S Segal","year":"1999","unstructured":"Segal S, Shifren JL, Isaacson KB, Leykin L, Chang Y, Pal L, et al. Effect of a baseline ovarian cyst on the outcome of in vitro fertilization-embryo transfer. Fertil Steril. 1999;71:274\u20137.","journal-title":"Fertil Steril"},{"issue":"6","key":"396_CR32","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S0015-0282(98)00333-1","volume":"70","author":"MM Biljan","year":"1998","unstructured":"Biljan MM, Mahutte NG, Dean N, Hemmings R, Bissonnette F, Tan SL. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil Steril. 1998;70(6):1063\u20139.","journal-title":"Fertil Steril"},{"key":"396_CR33","first-page":"CD006109","volume":"5","author":"C Farquhar","year":"2017","unstructured":"Farquhar C, Rombauts L, Kremer JA, Lethaby A, Ayeleke RO. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane Database Syst Rev. 2017;5:CD006109.","journal-title":"Cochrane Database Syst Rev"},{"key":"396_CR34","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.fertnstert.2020.05.021","volume":"114","author":"Y Lu","year":"2020","unstructured":"Lu Y, Wang Y, Zhang T, Wang G, He Y, Lindheim SR, et al. Effect of pretreatment oral contraceptives on fresh and cumulative live birth in vitro fertilization outcomes in ovulatory women. Fertil Steril. 2020;114:779\u201386.","journal-title":"Fertil Steril"},{"key":"396_CR35","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/humrep\/dez299","volume":"35","author":"P Montoya-Botero","year":"2020","unstructured":"Montoya-Botero P, Martinez F, Rodr\u00edguez-Purata J, Rodr\u00edguez I, Coroleu B, Polyzos NP. The effect of type of oral contraceptive pill and duration of use on fresh and cumulative live birth rates in IVF\/ICSI cycles. Hum Reprod. 2020;35:826\u201336.","journal-title":"Hum Reprod"},{"key":"396_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/humupd\/dmn015","volume":"14","author":"S Franks","year":"2008","unstructured":"Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008;14:367\u201378.","journal-title":"Hum Reprod Update"},{"key":"396_CR37","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/humrep\/deg266","volume":"18","author":"M Filicori","year":"2003","unstructured":"Filicori M, Cognigni GE, Ciampaglia W. Effects of LH on oocyte yield and developmental competence. Hum Reprod. 2003;18:1357\u20138.","journal-title":"Hum Reprod"},{"key":"396_CR38","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","volume":"86","author":"VL Nelson","year":"2001","unstructured":"Nelson VL, Qin KN, Rosenfield RL, et al. The biochemical basis for increased testosterone production in Theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86:5925\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"396_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/humupd\/3.2.95","volume":"3","author":"J Tesarik","year":"1997","unstructured":"Tesarik J, Mendoza C. Direct non-genomic effects of follicular steroids on maturing human oocytes: oestrogen versus androgen antagonism. Hum Reprod Update. 1997;3:95\u2013100.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"396_CR40","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1471-0528.1985.tb01113.x","volume":"92","author":"JD Stanger","year":"1985","unstructured":"Stanger JD, Yovich JL. Reduced in-vitro fertilization of human oocytes from patients with Raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol. 1985;92(4):385\u201393.","journal-title":"Br J Obstet Gynaecol"},{"issue":"Suppl 1","key":"396_CR41","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","volume":"46","author":"AE Schindler","year":"2003","unstructured":"Schindler AE, Campagnoli C, Druckmann R, et al. Classification and Pharmacology of progestins. Maturitas. 2003;46(Suppl 1):S7\u201316.","journal-title":"Maturitas"}],"container-title":["Contraception and Reproductive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40834-025-00396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40834-025-00396-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40834-025-00396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:50:48Z","timestamp":1781610648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40834-025-00396-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["396"],"URL":"https:\/\/doi.org\/10.1186\/s40834-025-00396-x","relation":{},"ISSN":["2055-7426"],"issn-type":[{"value":"2055-7426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the Medical Corporation Kobanawa Clinic Ethic Screening Committee\u3000(202311164) and in accordance with the Helsinki declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}